If you are considering GLP-1 therapy for Hashimoto's-related metabolic symptoms, an open and informed discussion with your GP or endocrinologist is essential
At Preferred Dermatology, our team provides GLP-1 injections to support medical weight loss
Retatrutide appears to cause more GI side effects than semaglutide, particularly nausea and vomiting, especially at higher doses
Additionally, its ability to improve insulin sensitivity and regulate adipose tissue inflammation makes it an attractive candidate for managing metabolic disorders beyond diabetes, such as non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome
These drugs mimic the action of naturally occurring GLP-1, an incretin hormone released by the intestine in response to food intake
Zepbound clocked $4.26 billion, a 122% increase